Vitamin K plasma levels determination in human health

Carregando...
Imagem de Miniatura
Citações na Scopus
88
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
WALTER DE GRUYTER GMBH
Autores
FUSARO, Maria
GALLIENI, Maurizio
RIZZO, Maria Antonietta
STUCCHI, Andrea
DELANAYE, Pierre
CAVALIER, Etienne
IERVASI, Giorgio
GIANNINI, Sandro
Citação
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, v.55, n.6, p.789-799, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Vitamin K (phylloquinone or vitamin K 1 and menaquinones or vitamin K 2) plays an important role as a cofactor in the synthesis of hepatic blood coagulation proteins, but recently has also aroused an increasing interest for its action in extra-hepatic tissues, in particular in the regulation of bone and vascular metabolism. The accurate measurement of vitamin K status in humans is still a critical issue. Along with indirect assays, such as the undercarboxylated fractions of vitamin K-dependent proteins [prothrombin, osteocalcin (OC), and matrix gla protein], the direct analysis of blood levels of phylloquinone and menaquinones forms might be considered a more informative and direct method for assessing vitamin K status. Different methods for direct quantification of vitamin K serum levels are available. High-performance liquid chromatography (HPLC) methods coupled with post-column reduction procedures and fluorimetric or electrochemical detection are commonly used for food and blood analysis of phylloquinone, but they show some limitations when applied to the analysis of serum menaquinones because of interferences from triglycerides. Recent advancements include liquid chromatography tandem mass spectrometry (LCMS/MS) detection, which assures higher specificity. The optimization and standardization of these methods requires specialized laboratories. The variability of results observed in the available studies suggests the need for further investigations to obtain more accurate analytical results.
Palavras-chave
human health, metabolism, plasma levels, vitamin K
Referências
  1. AKIYAMA Y, 1994, EUR J PHARMACOL, V263, P181, DOI 10.1016/0014-2999(94)90539-8
  2. AKIYAMA Y, 1993, JPN J PHARMACOL, V62, P145, DOI 10.1254/jjp.62.145
  3. Azharuddin MK, 2007, CLIN CHEM, V53, P1706, DOI 10.1373/clinchem.2007.086280
  4. Azuma K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119177
  5. Booth SL, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.5505
  6. Booth SL, 2009, ANNU REV NUTR, V29, P89, DOI 10.1146/annurev-nutr-080508-141217
  7. Booth SL, 1998, J NUTR, V128, P785
  8. Boxma PY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047991
  9. Braam LAJLM, 2004, THROMB HAEMOSTASIS, V91, P373, DOI 10.1160/TH03-07-0423
  10. Buranasinsup Shutipen, 2015, Journal of the Medical Association of Thailand, V98, pS16
  11. Caluwe R, 2014, NEPHROL DIAL TRANSPL, V29, P1385, DOI 10.1093/ndt/gft464
  12. Card DJ, 2009, BIOMED CHROMATOGR, V23, P1276, DOI 10.1002/bmc.1250
  13. Cham BE, 1999, CLIN CHIM ACTA, V287, P45, DOI 10.1016/S0009-8981(99)00117-5
  14. Cheung AM, 2008, PLOS MED, V5, P1776, DOI 10.1371/journal.pmed.0050196
  15. Cockayne S, 2006, ARCH INTERN MED, V166, P1256, DOI 10.1001/archinte.166.12.1256
  16. COMA (Committee on Medical Aspects of Food Policy), 1991, DIET REF VAL FOOD EN
  17. Cooper AD, 1997, J LIPID RES, V38, P2173
  18. Cranenburg ECM, 2010, THROMB HAEMOSTASIS, V104, P811, DOI 10.1160/TH09-11-0786
  19. Danziger J, 2008, CLIN J AM SOC NEPHRO, V3, P1504, DOI 10.2215/CJN.00770208
  20. Delanaye P, 2015, CLIN CHEM LAB MED, V53, pE191, DOI 10.1515/cclm-2015-0073
  21. Delanaye P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-145
  22. DiNicolantonio JJ, 2015, OPEN HEART, V2
  23. Ducros V, 2010, ANAL BIOCHEM, V401, P7, DOI 10.1016/j.ab.2010.02.018
  24. Elder SJ, 2006, J AGR FOOD CHEM, V54, P463, DOI 10.1021/jf052400h
  25. Expert Group on Vitamins and Minerals, 2003, SAF UPP LEV VIT MIN, P154
  26. Fusaro M, 2011, J ENDOCRINOL INVEST, V34, P317, DOI 10.3275/7353
  27. Fusaro M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133847
  28. Fusaro M, 2012, J BONE MINER RES, V27, P2271, DOI 10.1002/jbmr.1677
  29. Geleijnse JM, 2004, J NUTR, V134, P3100
  30. Gentili A, 2014, J CHROMATOGR A, V1338, P102, DOI 10.1016/j.chroma.2014.02.065
  31. Gundberg CM, 1998, J CLIN ENDOCR METAB, V83, P3258, DOI 10.1210/jc.83.9.3258
  32. Habu D, 2004, JAMA-J AM MED ASSOC, V292, P358, DOI 10.1001/jama.292.3.358
  33. HARA K, 1993, BONE, V14, P813, DOI 10.1016/8756-3282(93)90309-X
  34. Harrington DJ, 2007, J NUTR, V137, P1763
  35. Harrington DJ, 2010, PEDIATR RES, V68, P508, DOI 10.1203/PDR.0b013e3181f981c7
  36. HODGES SJ, 1991, BONE, V12, P387, DOI 10.1016/8756-3282(91)90027-G
  37. Kamao M, 2005, J CHROMATOGR B, V816, P41, DOI 10.1016/j.chromb.2004.11.003
  38. Kaneki M, 2001, NUTRITION, V17, P315, DOI 10.1016/S0899-9007(00)00554-2
  39. Karl JP, 2014, J CHROMATOGR B, V963, P128, DOI 10.1016/j.jchromb.2014.05.056
  40. Koitaya N, 2009, J NUTR SCI VITAMINOL, V55, P15, DOI 10.3177/jnsv.55.15
  41. KOSHIHARA Y, 1993, BIOCHEM PHARMACOL, V46, P1355, DOI 10.1016/0006-2952(93)90099-I
  42. Lamon-Fava S, 1998, AM J CLIN NUTR, V67, P1226
  43. Landes N, 2003, MOL ASPECTS MED, V24, P337, DOI 10.1016/S0098-2997(03)00029-3
  44. MACCREHAN WA, 1981, ANAL CHEM, V53, P1700, DOI 10.1021/ac00234a034
  45. McKeown NM, 2002, J NUTR, V132, P1329
  46. Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464
  47. Neogi T, 2006, ARTHRITIS RHEUM, V54, P1255, DOI 10.1002/art.21735
  48. Niemeier A, 2008, BONE, V43, P230, DOI 10.1016/j.bone.2008.03.022
  49. Ohsaki Y, 2006, BIOSCI BIOTECH BIOCH, V70, P926, DOI 10.1271/bbb.70.926
  50. Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200
  51. Oldenburg J, 2008, VITAM HORM, V78, P35, DOI 10.1016/S0083-6729(07)00003-9
  52. OLSON RE, 1984, ANNU REV NUTR, V4, P281
  53. ORIMO H, 1992, J BONE MINER RES, V7, pS122
  54. Paroni R, 2009, J CHROMATOGR B, V877, P351, DOI 10.1016/j.jchromb.2008.12.044
  55. Pilkey RM, 2007, AM J KIDNEY DIS, V49, P432, DOI 10.1053/j.ajkd.2006.11.041
  56. Riphagen IJ, 2016, CLIN CHEM LAB MED, V54, P1201, DOI 10.1515/cclm-2015-0864
  57. SAKANO T, 1986, CHEM PHARM BULL, V34, P4322
  58. Sato T, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-93
  59. Schlieper G, 2011, J AM SOC NEPHROL, V22, P387, DOI 10.1681/ASN.2010040339
  60. Schurgers LJ, 2002, BBA-GEN SUBJECTS, V1570, P27, DOI 10.1016/S0304-4165(02)00147-2
  61. Shea MK, 2008, AM J EPIDEMIOL, V167, P313, DOI 10.1093/aje/kwm306
  62. Shea MK, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010008
  63. Shearer MJ, 2008, THROMB HAEMOSTASIS, V100, P530, DOI 10.1160/TH08-03-0147
  64. SHINO M, 1988, ANALYST, V113, P393, DOI 10.1039/an9881300393
  65. Suhara Y, 2005, ANAL CHEM, V77, P757, DOI 10.1021/ac0489667
  66. Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200
  67. Teruya M, 2016, J Neonatal Perinatal Med, V9, P139, DOI 10.3233/NPM-16915084
  68. Thijssen HHW, 1996, BRIT J NUTR, V75, P121, DOI 10.1079/BJN19960115
  69. Thomas DDH, 2004, BIOCHEM BIOPH RES CO, V319, P974, DOI 10.1016/j.bbrc.2004.05.086
  70. Traber MG, 2008, NUTR REV, V66, P624, DOI 10.1111/j.1753-4887.2008.00123.x
  71. Tufano A, 2015, SEMIN THROMB HEMOST, V41, P382, DOI 10.1055/s-0034-1543999
  72. Institute of Medicine (US) Panel on Micronutrients, 2001, DIET REF INT VIT A V
  73. Vermeer C, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.5329
  74. Villines TC, 2005, CORONARY ARTERY DIS, V16, P199, DOI 10.1097/00019501-200505000-00010
  75. WAKABAYASHI H, 1992, J CHROMATOGR-BIOMED, V573, P154, DOI 10.1016/0378-4347(92)80490-H
  76. Westenfeld R, 2012, AM J KIDNEY DIS, V59, P186, DOI 10.1053/j.ajkd.2011.10.041
  77. Yamamoto R, 1997, J NUTR SCI VITAMINOL, V43, P133